share_log

Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Decreases By 21.9%

Defense World ·  Jul 6, 2022 15:01

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the recipient of a significant decline in short interest in the month of June. As of June 15th, there was short interest totalling 11,800 shares, a decline of 21.9% from the May 31st total of 15,100 shares. Based on an average daily trading volume, of 21,900 shares, the days-to-cover ratio is currently 0.5 days.

Shares of BIS opened at $24.68 on Wednesday. The stock's fifty day moving average price is $29.23 and its two-hundred day moving average price is $26.20. ProShares UltraShort Nasdaq Biotechnology has a 1 year low of $15.86 and a 1 year high of $35.64.

Get ProShares UltraShort Nasdaq Biotechnology alerts:

Several institutional investors and hedge funds have recently modified their holdings of the business. IMC Chicago LLC bought a new stake in shares of ProShares UltraShort Nasdaq Biotechnology during the 1st quarter valued at $450,000. OLD Mission Capital LLC bought a new stake in shares of ProShares UltraShort Nasdaq Biotechnology during the 4th quarter valued at $266,000. Finally, UBS Group AG raised its stake in shares of ProShares UltraShort Nasdaq Biotechnology by 54.7% during the 1st quarter. UBS Group AG now owns 1,371 shares of the company's stock valued at $33,000 after purchasing an additional 485 shares during the period.

About ProShares UltraShort Nasdaq Biotechnology (Get Rating)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.

Read More

  • Get a free copy of the StockNews.com research report on ProShares UltraShort Nasdaq Biotechnology (BIS)
  • Get Defensive With These Three Upgrades
  • Looking to Dump These 3 Possible Delisted Chinese Stocks? Let's Take a Look.
  • 3 Home Improvement Stocks That Can Renovate Your Portfolio
  • Vera Bradley Stock Getting Cheap
  • 3 Education Stocks to Enroll in This Summer

Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment